20 episodes
eBioMedicine in conversation with The Lancet Group
-
- Health & Fitness
Editors at eBioMedicine, in conversation with the journal’s authors, explore their latest research and its impact on people’s health, healthcare, and health policy.
A monthly audio companion to this open access journal, this podcast covers a broad range of topics, from climate change and health to microplastics in human tissues, the microbiome-gut-brain axis and binge drinking to computational pathology in 2030, and more.
-
Eddy Pasquier & Marion LeGrand on druggable cancer vulnerabilities
Drs. Pasquier and LeGrand join eBioMedicine to discuss their stepwise approach to unveil druggable cancer vulnerabilities and to fast-track the identification of synergistic combinations against glioblastoma.Read the full article:https://www.thelancet.com/journals/ebiom/article/PIIS2352-3964(23)00317-1/fulltext?dgcid=buzzsprout_icw_podcast_generic_ebiomContinue this conversation on social!Follow us today at...https://twitter.com/thelancethttps://instagram.com/thelancetgrouphttps://facebook.co...
-
Alan Dangour on climate change and health
Alan Dangour joins eBioMedicine to discuss climate change and health, our recently published Series, and projects they are working on at The Wellcome Trust.Read the full Series:https://www.thelancet.com/series/climate-change-and-health?dgcid=buzzsprout_icw_podcast_generic_ebiomContinue this conversation on social!Follow us today at...https://twitter.com/thelancethttps://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtu...
-
John Cryan on the microbiome-gut-brain axis and binge drinking
John Cryan joins eBioMedicine to discuss how the microbiome-gut-brain axis regulates social cognition and craving in young binge drinkers.Read the full article:https://www.thelancet.com/journals/ebiom/article/PIIS2352-3964(23)00007-5/fulltext?dgcid=buzzsprout_icw_podcast_generic_ebiomContinue this conversation on social!Follow us today at...https://twitter.com/thelancethttps://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps:...
-
Alvaro Berbís & David McClintock on computational pathology in 2030
Drs Berbís and McClintock join eBioMedicine to discuss the survey they conducted with experts, forecasting the role of AI in pathology within the next decade.Read the full article:https://www.thelancet.com/journals/ebiom/article/PIIS2352-3964(22)00609-0/fulltext?dgcid=buzzsprout_icw_podcast_ebiom_lancetContinue this conversation on social!Follow us today at...https://twitter.com/thelancethttps://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/compa...
-
Peter Robinson and Justin Reese on Long COVID subtypes
Drs Robinson and Reese join eBioMedicine to discuss their findings on semantic phenotypic clustering long COVID subtypes observed in N3C and RECOVER programmes.Read the full article:Generalisable long COVID subtypes: findings from the NIH N3C and RECOVER programmesContinue this conversation on social!Follow us today at...https://twitter.com/thelancethttps://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelan...
-
Ke-Wu Zeng on molecular glues for cancer therapy
Drs Zeng join eBioMedicine to discuss their study of a novel molecular glue, called bufalin.Read the full article:Atypical E3 ligase ZFP91 promotes small-molecule-induced E2F2 transcription factor degradation for cancer therapyContinue this conversation on social!Follow us today at...https://twitter.com/thelancethttps://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv